Sailaja Puttagunta
Nessuna posizione attualmente
Patrimonio netto: 15 554 $ in data 31/05/2024
Profilo
Sailaja Puttagunta worked as Vice President-Development & Medical Affairs at Durata Therapeutics, Inc. from 2012 to 2014.
She then served as Vice President-Medical Affairs at Allergan Ltd.
(Ireland) from 2015 to 2016.
From 2016 to 2018, she held the position of Vice President-Development at Iterum Therapeutics Plc.
Dr. Puttagunta was the Chief Medical Officer at BiomX Ltd.
from 2018 to 2019, and at BiomX, Inc. from 2019 to 2021.
Currently, she is the Chief Medical Officer at Iterum Therapeutics Plc, starting in 2021 and continuing until 2024.
Dr. Puttagunta graduated from New York University School of Medicine with a graduate degree and obtained her undergraduate degree from Gandhi Medical College & Hospital.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ITERUM THERAPEUTICS PLC
0.06% | 31/03/2024 | 10 369 ( 0.06% ) | 15 554 $ | 31/05/2024 |
Precedenti posizioni note di Sailaja Puttagunta
| Società | Posizione | Fine |
|---|---|---|
| ITERUM THERAPEUTICS PLC | Direttore Tecnico/Scientifico/R&S | 31/05/2024 |
| BIOMX INC. | Direttore Tecnico/Scientifico/R&S | 13/12/2021 |
BiomX Ltd.
 BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Direttore Tecnico/Scientifico/R&S | 01/10/2019 |
| ITERUM THERAPEUTICS PLC | Corporate Officer/Principal | 01/12/2018 |
| ALLERGAN PLC | Direttore Tecnico/Scientifico/R&S | 01/01/2016 |
Formazione di Sailaja Puttagunta
| Gandhi Medical College & Hospital | Undergraduate Degree |
| New York University School of Medicine | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| BIOMX INC. | Health Technology |
| ITERUM THERAPEUTICS PLC | Health Technology |
| Aziende private | 3 |
|---|---|
BiomX Ltd.
BiomX Ltd. Pharmaceuticals: MajorHealth Technology BiomX Ltd. engages in the development of customized phage therapies designed to target and destroy harmful bacteria in chronic diseases such as inflammatory bowel disease and colorectalcancer, as well as bacteria that affect the appearance of the skin. The company was founded by Eran Elinav, Timothy K. Lu, and Rotem Sorek on March 3, 2015 and is headquartered in Ness Ziona, Israel. | Health Technology |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
Durata Therapeutics, Inc.
 Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Durata Therapeutics, Inc. develops and commercializes novel therapeutics for infectious diseases and acute illnesses. The company was founded on November 4, 2009 and is headquartered in Chicago, IL. | Health Technology |
- Borsa valori
- Insiders
- Sailaja Puttagunta
